In conclusion, AS-IV inhibited cell viability and glycolysis of HCC by regulating KAT2A-mediated succinylation of PGAM1, which might provide new insights into the treatment of in HCC. This evidence concerns the gene KAT2A and hepatocellular carcinoma.